228 related articles for article (PubMed ID: 26375981)
1. Trans-Oval-Window Implants, A New Approach for Drug Delivery to the Inner Ear: Extended Dexamethasone Release From Silicone-based Implants.
Sircoglou J; Gehrke M; Tardivel M; Siepmann F; Siepmann J; Vincent C
Otol Neurotol; 2015 Sep; 36(9):1572-9. PubMed ID: 26375981
[TBL] [Abstract][Full Text] [Related]
2. Ear Cubes for local controlled drug delivery to the inner ear.
Gehrke M; Sircoglou J; Gnansia D; Tourrel G; Willart JF; Danede F; Lacante E; Vincent C; Siepmann F; Siepmann J
Int J Pharm; 2016 Jul; 509(1-2):85-94. PubMed ID: 27050866
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Ear Cubes for local controlled dexamethasone delivery to the inner ear.
Gehrke M; Verin J; Gnansia D; Tourrel G; Risoud M; Vincent C; Siepmann F; Siepmann J
Eur J Pharm Sci; 2019 Jan; 126():23-32. PubMed ID: 29723597
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants.
Liu Y; Jolly C; Braun S; Stark T; Scherer E; Plontke SK; Kiefer J
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1745-53. PubMed ID: 26319276
[TBL] [Abstract][Full Text] [Related]
5. Is oval window transport a royal gate for nanoparticle delivery to vestibule in the inner ear?
Ding S; Xie S; Chen W; Wen L; Wang J; Yang F; Chen G
Eur J Pharm Sci; 2019 Jan; 126():11-22. PubMed ID: 29499347
[TBL] [Abstract][Full Text] [Related]
6. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.
Liu Y; Jolly C; Braun S; Janssen T; Scherer E; Steinhoff J; Ebenhoch H; Lohner A; Stark T; Kiefer J
Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502
[TBL] [Abstract][Full Text] [Related]
7. A novel controlled local drug delivery system for inner ear disease.
Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
[TBL] [Abstract][Full Text] [Related]
8. Long-Term
Liebau A; Schilp S; Mugridge K; Schön I; Kather M; Kammerer B; Tillein J; Braun S; Plontke SK
Front Neurol; 2019; 10():1377. PubMed ID: 32038458
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid liposomal gel sustains delivery of a corticoid to the inner ear.
El Kechai N; Mamelle E; Nguyen Y; Huang N; Nicolas V; Chaminade P; Yen-Nicolaÿ S; Gueutin C; Granger B; Ferrary E; Agnely F; Bochot A
J Control Release; 2016 Mar; 226():248-57. PubMed ID: 26860286
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone eluting electrodes for cochlear implantation: Effect on residual hearing.
Douchement D; Terranti A; Lamblin J; Salleron J; Siepmann F; Siepmann J; Vincent C
Cochlear Implants Int; 2015 Jul; 16(4):195-200. PubMed ID: 24593762
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone Protects Against Apoptotic Cell Death of Cisplatin-exposed Auditory Hair Cells In Vitro.
Dinh CT; Chen S; Bas E; Dinh J; Goncalves S; Telischi F; Angeli S; Eshraghi AA; Van De Water T
Otol Neurotol; 2015 Sep; 36(9):1566-71. PubMed ID: 26375980
[TBL] [Abstract][Full Text] [Related]
12. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
[TBL] [Abstract][Full Text] [Related]
13. A comparison of systemic and local dexamethasone administration: From perilymph/cochlea concentration to cochlear distribution.
Wang Y; Han L; Diao T; Jing Y; Wang L; Zheng H; Ma X; Qi J; Yu L
Hear Res; 2018 Dec; 370():1-10. PubMed ID: 30223171
[TBL] [Abstract][Full Text] [Related]
14. Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs.
Arnold W; Senn P; Hennig M; Michaelis C; Deingruber K; Scheler R; Steinhoff HJ; Riphagen F; Lamm K
Audiol Neurootol; 2005; 10(1):53-63. PubMed ID: 15591792
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of a hydrogel reservoir as a continuous drug delivery system for inner ear treatment.
Hütten M; Dhanasingh A; Hessler R; Stöver T; Esser KH; Möller M; Lenarz T; Jolly C; Groll J; Scheper V
PLoS One; 2014; 9(8):e104564. PubMed ID: 25105670
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cochlear distribution and glucocorticoid receptor activation in local and systemic dexamethasone drug delivery regimes.
Creber NJ; Eastwood HT; Hampson AJ; Tan J; O'Leary SJ
Hear Res; 2018 Oct; 368():75-85. PubMed ID: 29622283
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant agents enhance round window membrane permeability to dexamethasone and modulate basal to apical cochlear gradients.
Creber NJ; Eastwood HT; Hampson AJ; Tan J; O'Leary SJ
Eur J Pharm Sci; 2019 Jan; 126():69-81. PubMed ID: 30107228
[TBL] [Abstract][Full Text] [Related]
18. Novel biodegradable Round Window Disks for inner ear delivery of dexamethasone.
Lehner E; Liebau A; Syrowatka F; Knolle W; Plontke SK; Mäder K
Int J Pharm; 2021 Feb; 594():120180. PubMed ID: 33338566
[TBL] [Abstract][Full Text] [Related]
19. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.
Hahn H; Kammerer B; DiMauro A; Salt AN; Plontke SK
Hear Res; 2006 Feb; 212(1-2):236-44. PubMed ID: 16442251
[TBL] [Abstract][Full Text] [Related]
20. Intracochlear Drug Delivery Through the Oval Window in Fresh Cadaveric Human Temporal Bones.
Kang WS; Nguyen K; McKenna CE; Sewell WF; McKenna MJ; Jung DH
Otol Neurotol; 2016 Mar; 37(3):218-22. PubMed ID: 26859540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
